ID

35005

Descripción

Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention; ODM derived from: https://clinicaltrials.gov/show/NCT02295059

Link

https://clinicaltrials.gov/show/NCT02295059

Palabras clave

Versiones (1)
  1. 8/2/19 8/2/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

8 de febrero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT02295059

Inglés

Eligibility Breast Cancer NCT02295059

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
prior diagnosis of stage 0 to iii breast cancer that is estrogen receptor negative, progesterone receptor negative with completion of definitive surgery, radiation therapy and/or chemotherapy.
Descripción

Breast Carcinoma Estrogen receptor negative TNM Breast tumor staging | Breast Carcinoma Progesterone receptor negative TNM Breast tumor staging | Operative Surgical Procedures Completion | Therapeutic radiology procedure Completion | Chemotherapy Completion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0279756
UMLS CUI [1,3]
C0474926
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0279766
UMLS CUI [2,3]
C0474926
UMLS CUI [3,1]
C0543467
UMLS CUI [3,2]
C0205197
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C0205197
UMLS CUI [5,1]
C0392920
UMLS CUI [5,2]
C0205197
completion of chemotherapy or trastuzumab for > six months and of radiation therapy for > 2 months, as applicable and 2 years or less from completion of standard therapy.
Descripción

Chemotherapy Completion | Trastuzumab Completion | Therapeutic radiology procedure Completion | Standard of Care Completion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C0728747
UMLS CUI [2,2]
C0205197
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0205197
UMLS CUI [4,1]
C2936643
UMLS CUI [4,2]
C0205197
greater than 1 year from pregnancy, lactation.
Descripción

Pregnancy Absent | Breast Feeding Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
mammogram within the six months prior to study enrollment that is not suspicious for breast cancer (acr class i-iii).
Descripción

Mammography | Absence Suspicion Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024671
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0242114
UMLS CUI [2,3]
C0678222
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
other current malignancy or metastatic malignancy of any kind.
Descripción

Cancer Other | Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2]
C0027627
ongoing chemotherapy, radiation therapy, or other cancer-related treatment.
Descripción

Chemotherapy | Therapeutic radiology procedure | Cancer treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0920425
subjects on coumadin or other anticoagulants.
Descripción

Coumadin | Anticoagulants

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0699129
UMLS CUI [2]
C0003280
subjects with breast implants.
Descripción

Breast implants

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0179412
subjects who have had radiation to both breasts or who have undergone bilateral mastectomies.
Descripción

Therapeutic radiology procedure Both breasts | Bilateral mastectomy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0222605
UMLS CUI [2]
C0191877
barriers to fine needle aspiration sampling of breast adipose tissue and/or parenchymal breast tissue, including breast implants, history of radiation to both breasts, bilateral mastectomies, and/or insufficient breast adipose/parenchymal tissue for adequate fine needle aspiration (fna) sampling.
Descripción

BARRIER Fine needle aspiration Sampling Fatty tissue of breast | BARRIER Fine needle aspiration Sampling Parenchymal Tissue Breast | Breast implants | Therapeutic radiology procedure Both breasts | Bilateral mastectomy | Fatty tissue of breast Insufficient Fine needle aspiration Sampling | Parenchymal Tissue Breast Insufficient Fine needle aspiration Sampling

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1706912
UMLS CUI [1,2]
C1510483
UMLS CUI [1,3]
C0441621
UMLS CUI [1,4]
C1305788
UMLS CUI [2,1]
C1706912
UMLS CUI [2,2]
C1510483
UMLS CUI [2,3]
C0441621
UMLS CUI [2,4]
C4277702
UMLS CUI [2,5]
C0006141
UMLS CUI [3]
C0179412
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C0222605
UMLS CUI [5]
C0191877
UMLS CUI [6,1]
C1305788
UMLS CUI [6,2]
C0231180
UMLS CUI [6,3]
C1510483
UMLS CUI [6,4]
C0441621
UMLS CUI [7,1]
C4277702
UMLS CUI [7,2]
C0006141
UMLS CUI [7,3]
C0231180
UMLS CUI [7,4]
C1510483
UMLS CUI [7,5]
C0441621
uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, hypertension, or psychiatric illness/social situation that would limit compliance with study requirements.
Descripción

Comorbidity Uncontrolled | Communicable Disease | Symptomatic congestive heart failure | Angina, Unstable | Cardiac Arrhythmia | Hypertensive disease | Mental disorders Limiting Protocol Compliance | Social situation Limiting Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0009450
UMLS CUI [3]
C0742758
UMLS CUI [4]
C0002965
UMLS CUI [5]
C0003811
UMLS CUI [6]
C0020538
UMLS CUI [7,1]
C0004936
UMLS CUI [7,2]
C0439801
UMLS CUI [7,3]
C0525058
UMLS CUI [8,1]
C0748872
UMLS CUI [8,2]
C0439801
UMLS CUI [8,3]
C0525058
chronic use of omega 3 fatty acid concentrates or capsules within the 3 months prior to entry on the study or any other supplements that might interact with omega 3 fatty acid supplements.
Descripción

Omega-3 Fatty Acids chronic | Supplements Interaction Omega-3 Fatty Acid Supplements

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0015689
UMLS CUI [1,2]
C0205191
UMLS CUI [2,1]
C0242295
UMLS CUI [2,2]
C0687133
UMLS CUI [2,3]
C0015689
UMLS CUI [2,4]
C0242295
pregnant or nursing women.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
known sensitivity or allergy to fish.
Descripción

Allergy to fish

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0856904
subjects on a standing regimen of full dose aspirin (greater than 325 mg/day), nsaids or nsaid-containing products.
Descripción

Aspirin Dose Full U/day | Anti-Inflammatory Agents, Non-Steroidal | Product Containing NSAIDs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0443225
UMLS CUI [1,4]
C0456683
UMLS CUI [2]
C0003211
UMLS CUI [3,1]
C1514468
UMLS CUI [3,2]
C0332256
UMLS CUI [3,3]
C0003211
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT02295059

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma Estrogen receptor negative TNM Breast tumor staging | Breast Carcinoma Progesterone receptor negative TNM Breast tumor staging | Operative Surgical Procedures Completion | Therapeutic radiology procedure Completion | Chemotherapy Completion
Item
prior diagnosis of stage 0 to iii breast cancer that is estrogen receptor negative, progesterone receptor negative with completion of definitive surgery, radiation therapy and/or chemotherapy.
boolean
C0678222 (UMLS CUI [1,1])
C0279756 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,3])
C0678222 (UMLS CUI [2,1])
C0279766 (UMLS CUI [2,2])
C0474926 (UMLS CUI [2,3])
C0543467 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C0392920 (UMLS CUI [5,1])
C0205197 (UMLS CUI [5,2])
Chemotherapy Completion | Trastuzumab Completion | Therapeutic radiology procedure Completion | Standard of Care Completion
Item
completion of chemotherapy or trastuzumab for > six months and of radiation therapy for > 2 months, as applicable and 2 years or less from completion of standard therapy.
boolean
C0392920 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0728747 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C2936643 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
Pregnancy Absent | Breast Feeding Absent
Item
greater than 1 year from pregnancy, lactation.
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Mammography | Absence Suspicion Breast Carcinoma
Item
mammogram within the six months prior to study enrollment that is not suspicious for breast cancer (acr class i-iii).
boolean
C0024671 (UMLS CUI [1])
C0332197 (UMLS CUI [2,1])
C0242114 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Cancer Other | Neoplasm Metastasis
Item
other current malignancy or metastatic malignancy of any kind.
boolean
C1707251 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
Chemotherapy | Therapeutic radiology procedure | Cancer treatment
Item
ongoing chemotherapy, radiation therapy, or other cancer-related treatment.
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0920425 (UMLS CUI [3])
Coumadin | Anticoagulants
Item
subjects on coumadin or other anticoagulants.
boolean
C0699129 (UMLS CUI [1])
C0003280 (UMLS CUI [2])
Breast implants
Item
subjects with breast implants.
boolean
C0179412 (UMLS CUI [1])
Therapeutic radiology procedure Both breasts | Bilateral mastectomy
Item
subjects who have had radiation to both breasts or who have undergone bilateral mastectomies.
boolean
C1522449 (UMLS CUI [1,1])
C0222605 (UMLS CUI [1,2])
C0191877 (UMLS CUI [2])
BARRIER Fine needle aspiration Sampling Fatty tissue of breast | BARRIER Fine needle aspiration Sampling Parenchymal Tissue Breast | Breast implants | Therapeutic radiology procedure Both breasts | Bilateral mastectomy | Fatty tissue of breast Insufficient Fine needle aspiration Sampling | Parenchymal Tissue Breast Insufficient Fine needle aspiration Sampling
Item
barriers to fine needle aspiration sampling of breast adipose tissue and/or parenchymal breast tissue, including breast implants, history of radiation to both breasts, bilateral mastectomies, and/or insufficient breast adipose/parenchymal tissue for adequate fine needle aspiration (fna) sampling.
boolean
C1706912 (UMLS CUI [1,1])
C1510483 (UMLS CUI [1,2])
C0441621 (UMLS CUI [1,3])
C1305788 (UMLS CUI [1,4])
C1706912 (UMLS CUI [2,1])
C1510483 (UMLS CUI [2,2])
C0441621 (UMLS CUI [2,3])
C4277702 (UMLS CUI [2,4])
C0006141 (UMLS CUI [2,5])
C0179412 (UMLS CUI [3])
C1522449 (UMLS CUI [4,1])
C0222605 (UMLS CUI [4,2])
C0191877 (UMLS CUI [5])
C1305788 (UMLS CUI [6,1])
C0231180 (UMLS CUI [6,2])
C1510483 (UMLS CUI [6,3])
C0441621 (UMLS CUI [6,4])
C4277702 (UMLS CUI [7,1])
C0006141 (UMLS CUI [7,2])
C0231180 (UMLS CUI [7,3])
C1510483 (UMLS CUI [7,4])
C0441621 (UMLS CUI [7,5])
Comorbidity Uncontrolled | Communicable Disease | Symptomatic congestive heart failure | Angina, Unstable | Cardiac Arrhythmia | Hypertensive disease | Mental disorders Limiting Protocol Compliance | Social situation Limiting Protocol Compliance
Item
uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, hypertension, or psychiatric illness/social situation that would limit compliance with study requirements.
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2])
C0742758 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0003811 (UMLS CUI [5])
C0020538 (UMLS CUI [6])
C0004936 (UMLS CUI [7,1])
C0439801 (UMLS CUI [7,2])
C0525058 (UMLS CUI [7,3])
C0748872 (UMLS CUI [8,1])
C0439801 (UMLS CUI [8,2])
C0525058 (UMLS CUI [8,3])
Omega-3 Fatty Acids chronic | Supplements Interaction Omega-3 Fatty Acid Supplements
Item
chronic use of omega 3 fatty acid concentrates or capsules within the 3 months prior to entry on the study or any other supplements that might interact with omega 3 fatty acid supplements.
boolean
C0015689 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0242295 (UMLS CUI [2,1])
C0687133 (UMLS CUI [2,2])
C0015689 (UMLS CUI [2,3])
C0242295 (UMLS CUI [2,4])
Pregnancy | Breast Feeding
Item
pregnant or nursing women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Allergy to fish
Item
known sensitivity or allergy to fish.
boolean
C0856904 (UMLS CUI [1])
Aspirin Dose Full U/day | Anti-Inflammatory Agents, Non-Steroidal | Product Containing NSAIDs
Item
subjects on a standing regimen of full dose aspirin (greater than 325 mg/day), nsaids or nsaid-containing products.
boolean
C0004057 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0443225 (UMLS CUI [1,3])
C0456683 (UMLS CUI [1,4])
C0003211 (UMLS CUI [2])
C1514468 (UMLS CUI [3,1])
C0332256 (UMLS CUI [3,2])
C0003211 (UMLS CUI [3,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial